Duopharma Biotech Bhd (7148) — Net Asset Quality Index
Duopharma Biotech Bhd (7148) has a Net Asset Quality Index of 52.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RM1.45 Billion minus total liabilities of RM690.68 Million yields net assets of RM757.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 7148 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Duopharma Biotech Bhd Net Asset Quality Index Over Time (2006–2025)
This chart shows how Duopharma Biotech Bhd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of December 2025, the index stands at 52.3%, representing net assets of RM757.62 Million against total assets of RM1.45 Billion MYR. See Duopharma Biotech Bhd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Duopharma Biotech Bhd (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Duopharma Biotech Bhd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 7148 company net worth.
| Year | Quality Index | Net Assets (MYR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.3% | RM757.62 Million | RM1.45 Billion | RM690.68 Million | ▲ +0.8 pp |
| 2024 | 51.5% | RM709.15 Million | RM1.38 Billion | RM667.85 Million | ▲ +0.4 pp |
| 2023 | 51.1% | RM687.12 Million | RM1.35 Billion | RM658.01 Million | ▼ -2.5 pp |
| 2022 | 53.6% | RM655.22 Million | RM1.22 Billion | RM566.70 Million | ▲ +0.0 pp |
| 2021 | 53.6% | RM624.00 Million | RM1.16 Billion | RM540.13 Million | ▼ -7.2 pp |
| 2020 | 60.8% | RM643.82 Million | RM1.06 Billion | RM414.61 Million | ▲ +3.2 pp |
| 2019 | 57.6% | RM529.75 Million | RM919.80 Million | RM390.05 Million | ▲ +0.1 pp |
| 2018 | 57.5% | RM481.04 Million | RM836.38 Million | RM355.34 Million | ▼ -10.5 pp |
| 2017 | 68.0% | RM479.87 Million | RM705.24 Million | RM225.38 Million | ▼ -0.7 pp |
| 2016 | 68.7% | RM454.52 Million | RM661.46 Million | RM206.95 Million | ▼ -2.3 pp |
| 2015 | 71.0% | RM449.72 Million | RM633.45 Million | RM183.73 Million | ▼ -16.0 pp |
| 2014 | 87.0% | RM193.63 Million | RM222.48 Million | RM28.85 Million | ▼ -1.8 pp |
| 2013 | 88.8% | RM182.65 Million | RM205.65 Million | RM23.00 Million | ▲ +2.7 pp |
| 2012 | 86.1% | RM170.50 Million | RM198.03 Million | RM27.53 Million | ▲ +2.8 pp |
| 2011 | 83.3% | RM164.44 Million | RM197.52 Million | RM33.08 Million | ▲ +2.9 pp |
| 2010 | 80.3% | RM157.87 Million | RM196.48 Million | RM38.61 Million | ▼ -2.0 pp |
| 2009 | 82.3% | RM142.74 Million | RM173.36 Million | RM30.63 Million | ▼ -4.5 pp |
| 2008 | 86.8% | RM130.55 Million | RM150.38 Million | RM19.83 Million | ▼ -2.9 pp |
| 2007 | 89.7% | RM114.21 Million | RM127.33 Million | RM13.12 Million | ▼ -1.8 pp |
| 2006 | 91.5% | RM145.43 Million | RM159.01 Million | RM13.58 Million | — |